{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Melanocortin receptor-specific cyclic peptides are reported with nanomolar or subnanomolar Ki values, for pharmaceutical development for many indications it is desired and necessary to optimize functionality, such as EC50 and Emax values, such that the peptides are agonists, preferably full agonists, more preferably potent full agonists, with nanomolar or subnanomolar EC50 values and Emax values as high as feasible, such as over about 80%, about 90% or at or over 100%.\n* Melanocortin receptor-specific peptides may be evaluated by a number of parameters, including binding affinities (typically Ki values reported in nM) and various functional measures, such as EC50 and Emax values."}
{"final_json": [{"molecule_name": "Melanocortin receptor-specific cyclic peptides", "protein_target_name": "Melanocortin receptor", "binding_metric": "Ki", "value": "nanomolar or subnanomolar", "unit": null}, {"molecule_name": "Melanocortin receptor-specific peptides", "protein_target_name": "Melanocortin receptor", "binding_metric": "Ki", "value": null, "unit": "nM"}, {"molecule_name": "Melanocortin receptor-specific cyclic peptides", "protein_target_name": "Melanocortin receptor", "binding_metric": "EC50", "value": "nanomolar or subnanomolar", "unit": null}, {"molecule_name": "Melanocortin receptor-specific cyclic peptides", "protein_target_name": "Melanocortin receptor", "binding_metric": "Emax", "value": "over about 80%, about 90%, or at or over 100%", "unit": null}]}
{"raw_mentions": "Unfortunately, there are no sentences in the provided text that meet the specified criteria, as they do not contain specific molecule names, bioactivity metrics (IC50, Ki, Kd, EC50), numeric values, and units. The text appears to be a descriptive passage about the invention, figures, and definitions, without providing specific data that matches the required format.\n\nIf you'd like, I can try to help you with anything else or provide more information on how to extract relevant data from a different text snippet."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* By way of example, a test compound which, at a concentration of 72 nM, produces 50% of the maximum possible response for that compound as determined in a cAMP assay in an MC4-R cell expression system has an EC50 of 72 nM.\n* Thus, by \u201cinhibition at 1 \u03bcM (NDP-\u03b1-MSH)\u201d is meant the percent decrease in binding of NDP-\u03b1-MSH by addition of a determined amount of the compound to be tested, such as 1 \u03bcM of a test compound, such as under the assay conditions hereafter described."}
{"final_json": [{"molecule_name": null, "protein_target_name": "MC4-R", "binding_metric": "EC50", "value": "72", "unit": "nM"}, {"molecule_name": "NDP-\u03b1-MSH", "protein_target_name": null, "binding_metric": null, "value": "1", "unit": "\u03bcM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nMembrane homogenates were incubated with 0.2 nM (for hMC4-R) 0.4 nM (for MC3-R and MC5-R) or 0.1 nM (for mouse B16 MC1-R or hMC1-R) [I<sup>125</sup>]-NDP-\u03b1-MSH (Perkin Elmer) and increasing concentrations of test peptides of the present invention in buffer containing 25 mM HEPES buffer (pH 7.5) with 100 mM NaCl, 2 mM CaCl<sub>2</sub>, 2 mM MgCl<sub>2</sub>, 0.3 mM 1,10-phenanthroline, and 0.2% bovine serum albumin.\nNon-specific binding was measured by inhibition of binding of [I<sup>125</sup>]-NDP-\u03b1-MSH in the presence of 1 \u03bcM NDP-\u03b1-MSH.\nTypically competition experiments to determine Ki values were conducted by incubating membrane homogenates prepared from HEK-293 cells that express recombinant hMC4-R with 9 different concentrations of test peptides of interest and 1 nM of Eu-NDP-\u03b1-MSH in a solution containing 25 mM HEPES buffer with 100 mM NaCl, 2 mM CaCl<sub>2</sub>, 2 mM MgCl<sub>2</sub>, 0.1% BSA and 0.3 mM 1,10-phenanthroline.\nCells were exposed for 15 minutes at 37\u00b0 C. to peptides of the present invention dissolved in DMSO (final DMSO concentration of 1%) at a concentration range of 0.05-5000 nM in a total assay volume of 200 \u03bcL."}
{"final_json": [{"molecule_name": "[I<sup>125</sup>]-NDP-\u03b1-MSH", "protein_target_name": "hMC4-R", "binding_metric": null, "value": "0.2", "unit": "nM"}, {"molecule_name": "[I<sup>125</sup>]-NDP-\u03b1-MSH", "protein_target_name": "MC3-R", "binding_metric": null, "value": "0.4", "unit": "nM"}, {"molecule_name": "[I<sup>125</sup>]-NDP-\u03b1-MSH", "protein_target_name": "MC5-R", "binding_metric": null, "value": "0.4", "unit": "nM"}, {"molecule_name": "[I<sup>125</sup>]-NDP-\u03b1-MSH", "protein_target_name": "mouse B16 MC1-R", "binding_metric": null, "value": "0.1", "unit": "nM"}, {"molecule_name": "[I<sup>125</sup>]-NDP-\u03b1-MSH", "protein_target_name": "hMC1-R", "binding_metric": null, "value": "0.1", "unit": "nM"}, {"molecule_name": "NDP-\u03b1-MSH", "protein_target_name": null, "binding_metric": null, "value": "1", "unit": "\u03bcM"}, {"molecule_name": "Eu-NDP-\u03b1-MSH", "protein_target_name": "hMC4-R", "binding_metric": "Ki", "value": null, "unit": null}, {"molecule_name": "peptides of the present invention", "protein_target_name": null, "binding_metric": null, "value": "0.05-5000", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nSuch peptides do not necessarily show increased binding affinity, such as measured by Ki values, compared to peptides wherein the lactam bridge amide bond is positioned by means of the side chains of Asp and Lys, but which are otherwise identical.\n\n\nIt has been found that a lactam bridge wherein the amide bond is positioned by means of the side chain of Glu or Orn (at the N-terminus of the cyclic portion) and the side chain of Orn or Glu (at the C-terminus end of the cyclic portion) has superior efficacy, such as efficacy determined by EC50 or Emax values, compared to peptides wherein the lactam bridge amide bond is positioned by means of the side chains of Asp and Lys, but which are otherwise identical."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "Ki", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Emax", "value": null, "unit": null}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 3K<sub>i</sub>Ec<sub>50</sub>E<sub>max</sub>Peptide Structure (Asp . . . Lys)(nM)(nM)(%)No.<img id=\"EMI-C00101\" path=\"US09273098-20160301-C00101.TIF\" file=\"https://surechembl.org/api/assets/attachment/333662127/US/20160301/B2/000009/27/30/98/US09273098-20160301-C00101.TIF\"/>42811 <img id=\"EMI-C00102\" path=\"US09273098-20160301-C00102.TIF\" file=\"https://surechembl.org/api/assets/attachment/333661635/US/20160301/B2/000009/27/30/98/US09273098-20160301-C00102.TIF\"/>0.42782 <img id=\"EMI-C00103\" path=\"US09273098-20160301-C00103.TIF\" file=\"https://surechembl.org/api/assets/attachment/333662016/US/20160301/B2/000009/27/30/98/US09273098-20160301-C00103.TIF\"/>224913 <img id=\"EMI-C00104\" path=\"US09273098-20160301-C00104.TIF\" file=\"https://surechembl.org/api/assets/attachment/333661842/US/20160301/B2/000009/27/30/98/US09273098-20160301-C00104.TIF\"/>21834 <img id=\"EMI-C00105\" path=\"US09273098-20160301-C00105.TIF\" file=\"https://surechembl.org/api/assets/attachment/333661645/US/20160301/B2/000009/27/30/98/US09273098-20160301-C00105.TIF\"/>564915 <img id=\"EMI-C00106\" path=\"US09273098-20160301-C00106.TIF\" file=\"https://surechembl.org/api/assets/attachment/333661974/US"}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "Ki", "value": null, "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Ec50", "value": null, "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Emax", "value": null, "unit": "%"}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not provide specific molecule names, IDs, or identifiers along with bioactivity metrics (IC50, Ki, Kd, EC50) and their corresponding numeric values with units. The text primarily discusses the effects of lactam shifts on functional efficacy and potency without providing specific data that includes all four required components."}
